COMMUNIQUÉ DE PRESSE publié le 18/03/2024 à 08:05, il y a 6 mois 1 jour BioNxt Reports Commercialization of ODF Cladribine Product for MS Next Steps BioNxt Solutions Inc. reports progress in toxicity and PK studies, advancing towards human comparative bioavailability studies. Development includes technology transfer, upscaling, & clinical sample prep for bioequivalence study BioNxt Solutions Inc. Toxicity Studies Comparative Pharmacokinetic Studies Bioavailability Pharmaceutical Drug Market
BRÈVE publiée le 13/03/2024 à 08:10, il y a 6 mois 6 jours BioNxt Reports Promising Results in ODF Cladribine Study for MS BioNxt Solutions Inc. Multiple Sclerosis Cladribine Pharmacokinetic Study Drug Delivery Technology
BRÈVE publiée le 13/03/2024 à 08:10, il y a 6 mois 6 jours BioNxt rapporte des résultats prometteurs dans l'étude ODF Cladribine pour la SEP BioNxt Solutions Inc. Sclérose En Plaques Cladribine Étude Pharmacocinétique Technologie D'administration De Médicaments
COMMUNIQUÉ DE PRESSE publié le 13/03/2024 à 08:05, il y a 6 mois 6 jours BioNxt Reports Successful Results From ODF Cladribine PK Study BioNxt Solutions Inc. announces successful completion of comparative pharmacokinetic study for its oral dissolvable film Cladribine product for Multiple Sclerosis treatment, demonstrating rapid absorption similar to reference drug BioNxt Solutions Inc. Multiple Sclerosis Cladribine Pharmacokinetic Study Drug Delivery System
COMMUNIQUÉ DE PRESSE publié le 17/02/2024 à 01:50, il y a 7 mois 2 jours BioNxt Solutions Finalizes Agreement BioNxt Solutions Inc. finalizes Settlement Agreement with a creditor to settle $282,415 debt through issuance of common shares and a cash payment. Debt to be settled in three instalments of shares based on market price Common Shares Debt Settlement BioNxt Solutions Inc. Settlement Agreement Creditor
COMMUNIQUÉ DE PRESSE publié le 30/01/2024 à 05:48, il y a 7 mois 20 jours BIONXT SOLUTIONS ANNOUNCES CLOSING OF FINAL TRANCHE OF NON-BROKERED PRIVATE PLACEMENT BioNxt Solutions Inc. closes final tranche of non-brokered private placement, raising gross proceeds of $288,000 to fund drug development and working capital purposes Private Placement Working Capital Investment Drug Development BioNxt Solutions Inc.
COMMUNIQUÉ DE PRESSE publié le 22/12/2023 à 09:05, il y a 8 mois 28 jours BioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and Financing
COMMUNIQUÉ DE PRESSE publié le 22/12/2023 à 01:50, il y a 8 mois 28 jours BioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and Financing
COMMUNIQUÉ DE PRESSE publié le 12/12/2023 à 09:05, il y a 9 mois 7 jours BioNxt Receives Delivery of Premium Commercial Coating and Cutting Equipment for Commercial Manufacturing of Drug Delivery Products
COMMUNIQUÉ DE PRESSE publié le 09/12/2023 à 04:30, il y a 9 mois 10 jours BioNxt Solutions Announces Completion of Debenture and Interest Settlement and Issuance of Finder’s Warrants
Publié le 19/09/2024 à 17:45, il y a 1 heure 9 minutes Gimv draagt helft van participatie in Infravest over aan WorxInvest (communicatie in toepassing van artikel 7:97 WVV)
Publié le 19/09/2024 à 17:45, il y a 1 heure 9 minutes Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Publié le 19/09/2024 à 17:45, il y a 1 heure 9 minutes Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Publié le 19/09/2024 à 17:30, il y a 1 heure 24 minutes Airborne Geophysical Survey Completed at Pine Channel Gold Project, Saskatchewan
Publié le 19/09/2024 à 17:00, il y a 1 heure 54 minutes Cypress Creek Consulting Advises Charter Communications on Inaugural Securitization Financing Facility
Publié le 19/09/2024 à 15:45, il y a 3 heures 9 minutes eLearners Make eLearning a Daily or Weekly Habit, Voices' eLearning Report Finds
Publié le 19/09/2024 à 15:20, il y a 3 heures 34 minutes Taurus secures "Best Digital Assets Solution" at 2024 Global BankTech Awards
Publié le 19/09/2024 à 15:01, il y a 3 heures 53 minutes ful. CashPay: Revolutionizing Healthcare Access for Employers With Uninsured Team Members
Publié le 19/09/2024 à 17:52, il y a 1 heure 1 minute PILOT 28 : FIGEAC AÉRO remporte 3 nouveaux contrats sur l'A320 pour 65 millions d'euros
Publié le 19/09/2024 à 17:52, il y a 1 heure 1 minute PILOT 28: FIGEAC AÉRO secures 3 new wins on the A320 airframe for 65 million euros
Publié le 19/09/2024 à 17:52, il y a 1 heure 2 minutes EQS-Adhoc: SMT Scharf AG: New CEO joins the Managing Board